2 min read

Narayana Hrudayalaya Moat Analysis: Score & Risks

Moat Note · First-pass

Narayana Hrudayalaya Ltd.

A first-pass moat teardown of Narayana Hrudayalaya Ltd., built from single-pass filing evidence. Free note — provisional, and the full two-pass deep dive may revise it.

Moat & Margin16 Aug 2026 First-pass · ~3 min
4.67 / 10
NARROWProcess/Data-led

First-pass narrow read — primary edge in Efficient Scale. Provisional, single-pass evidence.

Provisional score · subject to modification based on new evidence

Narayana Hrudayalaya Ltd. scores 4.67 on MoatSCORE 6.0 — a narrow moat in Pharma. This is a first-pass note: the dimensional read and the filing receipts below come from a single GFIP evidence pass, not the full two-pass deep corpus behind our flagship deep dives. Provisional — published free while the deep version is queued.

The teardown

Seven dimensions of moat

Ordered by contribution. Each dimension carries a verified filing quote, graded [M] mechanism or [O] outcome.

D6Efficient Scale5.5
No verified filing quote surfaced for this dimension in the first-pass evidence sweep.
D3Cost Advantage4.8
M · Mechanism Verified verbatim

“Estimated amounts of contracts remaining to be executed on capital account (net of advances) and other commitments and not provided for, amounts to Rs. 1,507.55 million (previous year: Rs. 1,017.18 million).”

Narayana Hrudayalaya Ltd. · Xbrl Text
D4Price Discretion4.8
M · Mechanism Verified verbatim

“But when it comes to pricing as compared to market, we would be at least 5 to 10% lower. I won't be able to indicate exact numbers, but in terms of numbers, will be slightly lower than the market in terms of pricing.”

Narayana Hrudayalaya Ltd. · Earnings Call · p.10
D1Network Effects4.5
O · Outcome Verified verbatim

“this business was at a EBITDA margin of 12% ex of the Birmingham asset. And this quarter we've done close to 10%.”

Narayana Hrudayalaya Ltd. · Earnings Call · p.24
1 quote extracted here — not one mechanism-class. The evidence is outcome-only.
D2Switching Costs4.5
M · Mechanism Verified verbatim

“The burn on clinics will start to increase. It was about INR 14.5 crores in Q3.”

Narayana Hrudayalaya Ltd. · Earnings Call · p.14
D5Intangible Assets4.5
M · Mechanism Verified verbatim

“Mr. Manohar D Chatlani resigned from the position of Independent Director of the Company with effect from January 18, 2021.”

Narayana Hrudayalaya Ltd. · Annual Report · p.61
D7Counter-PositioningExcluded
Excluded for this archetype.
D8Ungoverned RiskUnscored · Layer 2.5

D8 rating: ADEQUATE. Not part of the moat score — it governs the cost of equity and the fade window. First-pass; not yet deep-reviewed.

The barrier gate

The barrier gate — first-pass

Replication — can a rival copy it?5.0
How hard it is for a rival to copy the edge (first-pass estimate).
Bypass — can a rival route around it?5.0
How easily a rival can route around the edge (first-pass estimate).

Effective barrier 5 — below 6, so the band is capped narrow. First-pass estimate.

What would change our mind
  1. Deep two-pass review. This draft rests on a single GFIP evidence pass; the full 10-year AR + concall corpus may move the read.

  2. The barrier gate. A firmer replication or bypass estimate is the most likely thing to shift the band.

  3. Adverse events. Any governance, regulatory or funding shock captured in D8 could re-rate the fade window.

First-pass note — provisional single-pass MoatSCORE 6.0 read, not the full deep dive. Educational research, not investment advice; no buy/sell recommendation, no price target. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.